Guillermo A. Cabral-García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guillermo A. Cabral-García has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alma Barajas-Espinosa
Escuela Superior de Huejutla Universidad Autónoma del Estado de Hidalgo Huejutla de Reyes Hidalgo México
1 shared publication - Andrómeda Liñán-Rico
Centro Universitario de Investigaciones Biomédicas, Universidad de Colima Colima México
1 shared publication - Eduardo E. Valdez-Morales
Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico
1 shared publication - José R. Cruz-Muñoz
Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico
1 shared publication - Raquel Guerrero-Alba
Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes
1 shared publication
Latest Publications
- Open Access
- 28 September 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1291
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes
The role of P2X ionotropic receptors in the behavior of purinergic signaling on pathophysiological processes has been widely studied. In recent years, the important participation of P2X receptors in physiological and pathological processes, such as energy metabolism, characteristic inflammatory responses of the immune system, and nociceptive activity in response to pain stimuli, has been noted. Here, we explore the molecular characteristics of the P2X receptors and the use of the different agonist and antagonist agents recently described, focusing on their potential as new therapeutic targets in the treatment of diseases with emphasis on obesity, diabetes, and some of the complications derived from these pathologies.
- 28 September 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1291
Open AccessPharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes
The role of P2X ionotropic receptors in the behavior of purinergic signaling on pathophysiological processes has been widely studied. In recent years, the important participation of P2X receptors in physiological and pathological processes, such as energy metabolism, characteristic inflammatory responses of the immune system, and nociceptive activity in response to pain stimuli, has been noted. Here, we explore the molecular characteristics of the P2X receptors and the use of the different agonist and antagonist agents recently described, focusing on their potential as new therapeutic targets in the treatment of diseases with emphasis on obesity, diabetes, and some of the complications derived from these pathologies.